Surgical treatment of facial blushing: Patient selection and operative technique (retrospective observational study).
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
08 Jul 2022
08 Jul 2022
Historique:
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
12
7
2022
Statut:
epublish
Résumé
Surgeons are often reluctant to offer further intervention to patients with medically intractable facial blushing. This is mainly because of the relatively high failure rate of blushing resolution and a high incidence of compensatory hyperhidrosis. In this study, we sought to identify the type of blushing that would benefit from surgery and minimize compensatory hyperhidrosis by applying diffuse sympathicotomy (DS). This study was a retrospective review of 62 patients who underwent R2 endoscopic thoracic sympathicotomy (ETS) and preemptive DS for facial blushing. Facial blushing was classified as autonomic-mediated blushing (thermoregulatory, emotional) and vasodilator-mediated blushing (constant) based on the history and precipitating factors for blushing. DS was performed at lower-thoracic levels in the form of limited DS (right R5/7/9/11, left R5/6/8/10) or extended DS (bilateral R5-11). Resolution of blushing (described as "almost disappeared") was achieved in 48% of patients with a median follow-up of 19.6 months. There was a significant difference in resolution among 3 types of blushing (emotional: 55%, thermoregulatory: 28%, constant: 15%, P = .03). Multivariate analysis confirmed thermoregulatory and constant type blushing as a potential independent predictor of blushing resolution. Even though there was no difference between the DS procedures with respect to compensatory hyperhidrosis, intolerable compensatory hyperhidrosis (Hyperhidrosis Disease Severity Scale = 4) occurred in only 11% of patients. DS redistributed sweating area, being predominantly on the chest and mid-back (89%), also seen on the abdomen-waist-groin-buttocks-thighs (63%). Overall, 77% of patients experienced satisfactory results. Emotional blushing proved to be an established indication of ETS where good long-term results can be expected. Expansion of surgical indication to thermoregulatory or constant type blushing needs to be validated in future studies. Additionally, compensatory hyperhidrosis, another hurdle for ETS, can be minimized by preemptive DS, resulting in redistribution and decrease of sweating.
Identifiants
pubmed: 35801793
doi: 10.1097/MD.0000000000029808
pii: 00005792-202207080-00064
pmc: PMC9259148
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29808Informations de copyright
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Drummond PD, Lance JW. Facial flushing and sweating mediated by the sympathetic nervous system. Brain. 1987;110:793–803.
Collin J, Whatling P. Treating hyperhidrosis. Surgery and botulinum toxin are treatments of choice in severe cases. BMJ. 2000;320:1221–2.
Drott C, Claes G, Rex L. Facial blushing treated by sympathetic denervation—longlasting benefits in 831 patients. J Cosmet Dermatol. 2002;1:115–9.
Girish G, D’Souza RE, D’Souza P, et al. Role of surgical thoracic sympathetic interruption in treatment of facial blushing: a systematic review. Postgrad Med. 2017;129:267–75.
Jadresic E, Suarez C, Palacios E, et al. Evaluating the efficacy of endoscopic thoracic sympathectomy for generalized social anxiety disorder with blushing complaints: a comparison with sertraline and no treatment—Santiago De Chile 2003-2009. Innov Clin Neurosci. 2011;8:24–35.
Kristian S, Christer D. Facial blushing: patient selection and long-term results. Thorac Surg Clin. 2016;26:459–63.
Licht PB, Ladegaard L, Pilegaard HK. Thoracoscopic sympathectomy for isolated facial blushing. Ann Thorac Surg. 2006;81:1863–6.
Licht PB, Pilegaard HK. Management of facial blushing. Thorac Surg Clin. 2008;18:223–8.
Licht PB, Pilegaard HK, Ladegaard L. Sympathicotomy for isolated facial blushing: a randomized clinical trial. Ann Thorac Surg. 2012;94:401–5.
Rex LO, Drott C, Claes G, et al. The Boras experience of endoscopic thoracic sympathicotomy for palmar, axillary, facial hyperhidrosis and facial blushing. Eur J Surg Suppl. 1998:23–6.
Smidfelt K, Drott C. Late results of endoscopic thoracic sympathectomy for hyperhidrosis and facial blushing. Br J Surg. 2011;98:1719–24.
Kwong KF, Cooper LB, Bennett LA, et al. Clinical experience in 397 consecutive thoracoscopic sympathectomies. Ann Thorac Surg. 2005;80:1063–6.
Moon MH, Hyun K, Park JK, et al. Surgical treatment of compensatory hyperhidrosis: retrospective observational study. Medicine (Baltimore). 2020;99:e22466–e22466.
Drott C. Results of endoscopic thoracic sympathectomy (ETS) on hyperhidrosis, facial blushing, angina pectoris, vascular disorders and pain syndromes of the hand and arm. Clin Auton Res. 2003;13(Suppl 1):I26–30.
O’Riordain DS, Maher M, Waldron DJ, et al. Limiting the anatomic extent of upper thoracic sympathectomy for primary palmar hyperhidrosis. Surg Gynecol Obstet. 1993;176:151–4.